Accelerated fetal lung maturity profiles and maternal cocaine exposure

Obstetrics and Gynecology

Volumn 87, Issue 1, 1996, Pages 128-132

  Hanlon Lundberg, Kathleen M ^a   Williams, Michelle ^b   Rhim, Teresa ^b   Covert, Robert F ^b   Mittendorf, Robert ^b   Holt, John A ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; COCAINE; LUNG SURFACTANT;

ADULT; AMNION FLUID; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DRUG ABUSE; FEMALE; FETUS LUNG MATURITY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; PRENATAL EXPOSURE; PRIORITY JOURNAL;

EID: 0030044943     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(95)00353-3     Document Type: Article

References (28)

1. Chasnoff IJ. Drug use and women. Establishing a standard of care. Ann N Y Acad Sci 1989;562:208-10.
2. Ostrea EM, Welch RA. Detection of prenatal drug exposure in the pregnant woman and her newborn. Clin Perinatol 1991;18:629-45.
3. Vega WA, Kolody B, Hwang J, Noble A. Prevalence and magnitude of perinatal substance exposures in California. N Engl J Med 1993;329:850-4.
4. Osterloh JD, Lee BL. Testing for drugs of abuse. Pharmacokinetic considerations for cocaine in urine. Clin Pharmacokinet 1993;24: 355-61.
5. Chasnoff IJ, Burns WJ, Schnoll SH, Burns KA. Cocaine use in pregnancy. N Engl J Med 1985;313:666-9.
6. MacGregor SN, Keith LG, Chasnoff IJ, et al. Cocaine use during pregnancy: Adverse perinatal outcome. Am J Obstet Gynecol 1987;157:686-90.
7. Shinitzky M, Goldfisher A, Bruck A, Goldman B, Stern E, Barkai G. A new method for assessment of fetal lung maturity. Br J Obstet Gynaecol 1976;83:838-44.
8. Tait JF, Franklin RW, Simpson JB, Ashwood ER. Improved fluorescence polarization assay for use in evaluating fetal lung maturity. I. Development of the assay procedure. Clin Chem 1986;33: 1177-84.
9. Ashwood ER, Tait JF, Foerder CA, Franklin RW, Benedetti TJ. Improved fluorescence polarization assay for use in evaluating fetal lung maturity: III. Retrospective clinical evaluation and comparison with the lecithin/sphingomyelin ratio. Clin Chem 1986;32:260-4.
10. Ashwood ER, Palmer SE, Lenke RR. Rapid fetal lung maturity testing: Commercial versus N BD-phosphatidylcholine assay. Obstet Gynecol 1992;80:1048-53.
11. Tait JF, Foerder CA, Ashwood ER, Benedetti TJ. Prospective clinical evaluation of an improved fluorescence polarization assay for predicting fetal lung maturity. Clin Chem 1987;33:554-8.
12. Francoual J, Benatter C, Vial M, Papiernik E, Leluc R, Lindenbaum A. Fast determination of pulmonary surfactant in amniotic fluid using fluorescence polarization (FLM test Abbott). Gynecol Obstet Biol Reprod (Paris) 1991;20:425-8.
13. Russell JC, Cooper CM, Ketchum CH, et al. Multicenter evaluation of TDx test for assessing fetal lung maturity. Clin Chem 1989;35: 1005-10.
14. Holt JA, Ryan DF, Russell JC, Cooper CM, Moawad AH, Zibrat SJ. Automated rapid assessment of surfactant and fetal lung maturity. Lab Med 1990;21:359-66.
15. Herbert WNP, Chapman JF, Schnoor MM. Rule of the TDx-FLM assay in fetal lung maturity. Am J Obstet Gynecol 1993;168:808-12.
16. Hagen E, Link JC, Arias F A comparison of the accuracy of the TDx-FLM assay, lecithin-sphingomyelin ratio, and phosphatidylglycerol in the prediction of neonatal respiratory distress syndrome. Obstet Gynecol 1993;82:1004-8.
17. Zuckerman B, Maynard EC, Cabral H. A preliminary report of prenatal cocaine exposure and respiratory distress syndrome in premature infants. Am J Dis Child 1991;145:696-8.
18. Dusick AM, Covert RF, Schreiber MD. et al. Risk of intracranial hemorrhage and other adverse outcomes after cocaine exposure in a cohort of 323 very-low-birthweight babies. J Pediatr 1993;122: 438-45.
19. Beeram MR, Abedin M, Young M, Leftridge C, Dhanireddy R. Effect of intrauterine cocaine exposure on respiratory distress syndrome in very low birth weight infants. J Natl Med Assoc 1994;86:370-2.
20. Steinfeld JD, Samuels P, Bulley MA, Cohen AW, Goodman DB, Senior MB. The utility of the TDx test in the assessment of fetal lung maturity. Obstet Gynecol 1492;74:460-4.
21. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1984;74:340-4.
22. Kain ZN, Chinoy MR, Antonio-Santiago MT, Marchitelli RN, Scarpelli EM. Enhanced lung maturation in cocaine-exposed rabbit fetuses. Pediatr Res 1491;24:534-7.
23. Chasnoff IJ. Hunt CE, Kletter R, Kaplan D. Prenatal cocaine exposure is associated with respiratory pattern abnormalities. Am J Dis Child 1989;143:583-7.
24. Berkowitz RL, Kantor RD, Beck GJ, Warshaw JB. The relationship between premature rupture of the membranes and the respiratory distress syndrome: An update and plan of management. Am J Obstet Gynecol 1478;131:503-8.
25. Schreiber J, Benedetti T. Conservative management of preterm premature rupture of the fetal membranes in a low socioeconomic population. Am J Obstet Gynecol 1980;136:92-6.
26. Jones M, Burd L, Bowes W, Battaglia F, Lubchenco L. Failure of association of premature rupture of membranes with respiratory distress syndrome. N Engl J Med 1975;292:1253-7.
27. Hallak M, Bottoms SF. Accelerated pulmonary maturation from preterm premature rupture of membranes: A myth. Am J Obstet Gynecol 1993;169:1045-9.
28. Schiff E, Friedman SA, Mercer BM, Sibai BM. Fetal lung maturity is not accelerated in preeclamptic pregnancies. Am J Obstet Gynecol 1993;169:1091-101.